X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28162) 28162
Book Chapter (55) 55
Newsletter (36) 36
Newspaper Article (29) 29
Publication (7) 7
Dissertation (4) 4
Conference Proceeding (2) 2
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (19179) 19179
humans (11580) 11580
nitric oxide (10618) 10618
mice (9752) 9752
nitric-oxide synthase (9518) 9518
male (8775) 8775
rats (6006) 6006
nitric-oxide (5794) 5794
female (5096) 5096
oxidative stress (4761) 4761
nitric oxide - metabolism (4633) 4633
nitric oxide synthase type ii - metabolism (4459) 4459
inflammation (4419) 4419
expression (4357) 4357
nitric oxide synthase type ii - genetics (4158) 4158
cell biology (4064) 4064
nitric oxide synthase type ii (4037) 4037
biochemistry & molecular biology (3865) 3865
nitric oxide synthase - genetics (3588) 3588
gene expression (3433) 3433
mice, inbred c57bl (3316) 3316
rodents (3296) 3296
cells, cultured (3280) 3280
immunology (3251) 3251
physiology (2996) 2996
proteins (2969) 2969
apoptosis (2877) 2877
research (2874) 2874
activation (2751) 2751
mice, knockout (2733) 2733
nitric oxide synthase - metabolism (2712) 2712
neurosciences (2691) 2691
disease models, animal (2606) 2606
rna, messenger - metabolism (2575) 2575
signal transduction (2567) 2567
physiological aspects (2546) 2546
research article (2513) 2513
pharmacology & pharmacy (2470) 2470
analysis (2461) 2461
cytokines (2432) 2432
macrophages (2336) 2336
multidisciplinary sciences (2311) 2311
medicine (2300) 2300
cell line (2285) 2285
inhibition (2191) 2191
endothelium (2190) 2190
nf-kappa-b (2090) 2090
cells (2089) 2089
rats, sprague-dawley (2043) 2043
health aspects (2042) 2042
hypertension (1996) 1996
gene-expression (1970) 1970
nf-kappa b - metabolism (1861) 1861
nitric oxide - biosynthesis (1811) 1811
science (1792) 1792
biology (1740) 1740
phosphorylation (1709) 1709
rna, messenger - genetics (1707) 1707
genetic aspects (1706) 1706
enzymes (1700) 1700
enzyme inhibitors - pharmacology (1651) 1651
kinases (1641) 1641
reverse transcriptase polymerase chain reaction (1633) 1633
rats, wistar (1582) 1582
medicine, research & experimental (1573) 1573
lipopolysaccharides - pharmacology (1564) 1564
immunohistochemistry (1507) 1507
middle aged (1502) 1502
adult (1501) 1501
reactive oxygen species - metabolism (1484) 1484
peripheral vascular disease (1449) 1449
risk factors (1417) 1417
macrophages - metabolism (1405) 1405
nitric oxide synthase type iii - metabolism (1397) 1397
in-vivo (1378) 1378
life sciences (1370) 1370
endocrinology & metabolism (1357) 1357
oncology (1348) 1348
cardiac & cardiovascular systems (1347) 1347
blotting, western (1345) 1345
disease (1300) 1300
diabetes (1296) 1296
metabolism (1287) 1287
atherosclerosis (1281) 1281
review (1268) 1268
signal transduction - drug effects (1263) 1263
macrophages - drug effects (1258) 1258
nitric oxide synthase type iii (1252) 1252
cancer (1246) 1246
nitric oxide synthase type iii - genetics (1245) 1245
dose-response relationship, drug (1238) 1238
in-vitro (1232) 1232
time factors (1228) 1228
antioxidants (1209) 1209
studies (1174) 1174
up-regulation (1171) 1171
nitric oxide synthase (1152) 1152
biochemistry (1123) 1123
brain (1098) 1098
induction (1077) 1077
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28206) 28206
Japanese (158) 158
Chinese (150) 150
Portuguese (25) 25
Russian (19) 19
German (9) 9
French (6) 6
Polish (6) 6
Spanish (6) 6
Dutch (3) 3
Norwegian (3) 3
Ukrainian (2) 2
Hungarian (1) 1
Korean (1) 1
Lithuanian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Trends in immunology, ISSN 1471-4906, 2015, Volume 36, Issue 3, pp. 161 - 178
....•NOS2-positive mesenchymal stem cells and lymphatic stromal cells suppress T cells. Thirty years after the discovery of its production by activated macrophages, our appreciation of the diverse roles of nitric oxide (NO) continues to grow... 
Allergy and Immunology | microenvironment | NOS3/eNOS | myeloid cells | nitric oxide synthases (NOS1/nNOS | antimicrobial activity | B cells | NOS2/iNOS | Th17 cells | Antimicrobial activity | Myeloid cells | Microenvironment | Nitric oxide synthases (NOS1/nNOS | nitric oxide synthases (NOS1/nNOS; NOS2/iNOS; NOS3/eNOS) | SIGNALING PATHWAYS | ALZHEIMERS-DISEASE | HYDROGEN-SULFIDE | IMMUNOLOGY | MESENCHYMAL STEM-CELLS | S-NITROSYLATION | REACTIVE OXYGEN | MESSENGER-RNA | L-ARGININE | HEME OXYGENASE-1 | MOUSE MACROPHAGES | Adaptive Immunity | Nitric Oxide - biosynthesis | Nitric Oxide - immunology | Signal Transduction | Isoenzymes - genetics | Humans | Gene Expression Regulation | STAT Transcription Factors - immunology | Immunity, Innate | Interferon-Stimulated Gene Factor 3, gamma Subunit - genetics | Isoenzymes - immunology | Macrophage Activation | Bacteria - immunology | STAT Transcription Factors - genetics | Lymphocytes - immunology | Neoplasms - genetics | Nitric Oxide Synthase Type II - genetics | Nitric Oxide Synthase Type II - immunology | Neoplasms - immunology | Interferon-Stimulated Gene Factor 3, gamma Subunit - immunology | Neoplasms - pathology | Macrophages - immunology | Nitric oxide | Stem cells | Enzymes | Gram-positive bacteria | Cell division | Nitrates | Metastasis | Cell adhesion & migration | Proteins | Immunology | Lymphocytes | Cell cycle | Hypoxia | Sulfur | Immune system
Journal Article
Nature (London), ISSN 1476-4687, 2019, Volume 568, Issue 7752, pp. 351 - 356
.... Here we report that concomitant metabolic and hypertensive stress in mice-elicited by a combination of high-fat diet and inhibition of constitutive nitric oxide synthase using N-omega-nitro-larginine methyl ester (L-NAME... 
S-NITROSYLATION | INHIBITION | DYSFUNCTION | MODEL | NITRIC-OXIDE SYNTHASE | MULTIDISCIPLINARY SCIENCES | Humans | Heart Failure - physiopathology | Diet, High-Fat - adverse effects | Male | Heart Failure - prevention & control | Myocytes, Cardiac - enzymology | Nitric Oxide Synthase Type II - antagonists & inhibitors | Protein-Serine-Threonine Kinases - metabolism | Disease Models, Animal | NG-Nitroarginine Methyl Ester - pharmacology | Endoribonucleases - metabolism | Signal Transduction | Mice, Inbred C57BL | Nitric Oxide Synthase Type II - deficiency | Heart Failure - metabolism | Nitrosative Stress | Stroke Volume | Myocytes, Cardiac - pathology | Phenotype | Animals | Nitric Oxide Synthase Type II - genetics | X-Box Binding Protein 1 - metabolism | Myocytes, Cardiac - metabolism | Mice | X-Box Binding Protein 1 - genetics | Nitric Oxide Synthase Type II - metabolism | Heart failure | Care and treatment | Diagnosis | Health aspects | Nitric oxide | Heart | Genetic suppression | Kinases | High fat diet | Proteins | Arginine | Protein folding | Heart diseases | Hypertension | Obesity | Phenotypes | Inositol | Splicing | Cardiomyocytes | Pharmacology | Inflammation | Metabolism | Morbidity | Nitric-oxide synthase | NG-Nitroarginine methyl ester | Musculoskeletal system | Diet | Myocardium | Endonuclease | Ejection fraction
Journal Article
Molecular Pain, ISSN 1744-8069, 3/2010, Volume 6, Issue 1, pp. 13 - 13
Background: Although it has been largely demonstrated that nitric oxide synthase (NOS... 
PROINFLAMMATORY CYTOKINE | NEUROPATHIC PAIN | MECHANICAL ALLODYNIA | SPINAL-CORD | NECROSIS-FACTOR-ALPHA | INFLAMMATORY PAIN | PRIMARY SENSORY NEURONS | PHARMACOLOGICAL INHIBITION | PATHOLOGICAL PAIN | NEUROSCIENCES | NERVE GROWTH-FACTOR | Interleukin-1beta - drug effects | Tumor Necrosis Factor-alpha - metabolism | Gene Expression Regulation, Enzymologic - drug effects | Freund's Adjuvant - pharmacology | Tumor Necrosis Factor-alpha - genetics | Nitric Oxide Synthase - antagonists & inhibitors | Male | Interleukin-1beta - genetics | Nitric Oxide Synthase - genetics | RNA, Messenger - metabolism | Inflammation Mediators - pharmacology | Interleukin-1beta - metabolism | Isoenzymes - metabolism | Nitric Oxide Synthase Type II - antagonists & inhibitors | Nitric Oxide Synthase Type I - antagonists & inhibitors | Interleukin-10 - metabolism | Nitric Oxide Synthase Type III - metabolism | Cytokines - genetics | Disease Models, Animal | RNA, Messenger - drug effects | NG-Nitroarginine Methyl Ester - pharmacology | Nitric Oxide - biosynthesis | Cytokines - metabolism | Mice, Inbred C57BL | Enzyme Inhibitors - pharmacology | Nitric Oxide Synthase Type III - genetics | Hyperalgesia - physiopathology | Mice, Knockout | Nitric Oxide Synthase Type III - antagonists & inhibitors | Hyperalgesia - immunology | Animals | Sensory Receptor Cells - drug effects | Tumor Necrosis Factor-alpha - drug effects | Cytokines - drug effects | Nitric Oxide Synthase Type II - genetics | Interleukin-10 - genetics | Nitric Oxide Synthase Type I - metabolism | Mice | Nitric Oxide Synthase - metabolism | Nitric Oxide Synthase Type I - genetics | Hyperalgesia - enzymology | Nociceptors - drug effects | Nitric Oxide Synthase Type II - metabolism | Physiological aspects | Rats | Research | Cytokines | Nitric oxide | Rattus
Journal Article
The Journal of biological chemistry, ISSN 1083-351X, 2014, Volume 289, Issue 40, pp. 27540 - 27550
Journal Article
Nature immunology, ISSN 1529-2916, 2011, Volume 12, Issue 11, pp. 1096 - 1104
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 10, p. e76538
Background: Simvastatin exerts pleiotropic effects on cardiovascular system. However, its effect on non-alcoholic fatty liver disease, especially the liver... 
PATHOGENESIS | ISSUES | HEPATIC STELLATE CELLS | MANAGEMENT | STEATOSIS | MULTIDISCIPLINARY SCIENCES | DISEASE | FATTY LIVER | STATINS | EXPRESSION | Liver - pathology | Liver - enzymology | Gene Expression - drug effects | Rats, Wistar | Fatty Liver - pathology | Humans | Actins - metabolism | Diet, High-Fat - adverse effects | Male | Liver Cirrhosis - enzymology | Simvastatin - pharmacology | Actins - genetics | Collagen Type I - genetics | Liver - drug effects | Nitric Oxide Synthase Type II - antagonists & inhibitors | Fatty Liver - enzymology | Non-alcoholic Fatty Liver Disease | Nitric Oxide Synthase Type III - metabolism | Hepatic Stellate Cells - pathology | Transforming Growth Factor beta1 - pharmacology | Hepatic Stellate Cells - drug effects | NG-Nitroarginine Methyl Ester - pharmacology | Liver Cirrhosis - etiology | Collagen Type I - metabolism | Liver Cirrhosis - prevention & control | Collagen Type I - antagonists & inhibitors | Cells, Cultured | Enzyme Inhibitors - pharmacology | Hepatic Stellate Cells - enzymology | Rats | Hypolipidemic Agents - pharmacology | Nitric Oxide Synthase Type III - genetics | Fatty Liver - drug therapy | Actins - antagonists & inhibitors | Animals | Nitric Oxide Synthase Type II - genetics | Liver Cirrhosis - pathology | Fatty Liver - etiology | Nitric Oxide Synthase Type II - metabolism | Complications and side effects | Simvastatin | Fibrosis | Genetic aspects | Dosage and administration | Research | Drug therapy | Animal models | RNA-directed DNA polymerase | Liver | Collagens | Smooth muscle | Cardiovascular disease | Activation | Arthritis | High fat diet | Proteins | Fatty liver | Arginine | Ischemia | Actin | Rodents | Hepatology | Gastroenterology | Inhibition | Growth factors | Cardiovascular system | Medical research | Phenotypes | Liver diseases | Muscles | Nitric-oxide synthase | NG-Nitroarginine methyl ester | Polymerase chain reaction | Infectious diseases | Hospitals | Nitric oxide | MicroRNAs | Collagen | In vivo methods and tests | In vitro methods and tests
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2011, Volume 129, Issue 1, pp. 232 - 239.e7
Journal Article